Masimo Must Face FCA Claims That It Peddled Shoddy Devices

Law360, New York (July 10, 2012, 5:29 PM EDT) -- A California federal judge on Monday largely preserved a suit by former Masimo Corp. sales representatives claiming the patient-monitoring technology firm fraudulently caused Medicare and other government programs to pay reimbursements for its allegedly defective hemoglobin measurement devices.

U.S. District Judge Cormac J. Carney, preserved the relators’ claims that Masimo’s alleged conduct violated the False Claims Act, finding that the scope of the FCA is broad enough to cover all fraudulent efforts to solicit large reimbursements from the government. Judge Carney's ruling sloughed off only the...
To view the full article, register now.